WS Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-30,953
| Closed | -$2.98M | – | 38 |
|
|
2023
Q4 | $2.98M | Hold |
30,953
| – | – | 0.18% | 34 |
|
|
2023
Q3 | $2.74M | Hold |
30,953
| – | – | 0.22% | 33 |
|
|
2023
Q2 | $2.68M | Hold |
30,953
| – | – | 0.22% | 33 |
|
|
2023
Q1 | $3.01M | Hold |
30,953
| – | – | 0.32% | 31 |
|
|
2022
Q4 | $3.2M | Hold |
30,953
| – | – | 0.27% | 32 |
|
|
2022
Q3 | $2.62M | Hold |
30,953
| – | – | 0.24% | 31 |
|
|
2022
Q2 | $2.57M | Hold |
30,953
| – | – | 0.21% | 35 |
|
|
2022
Q1 | $2.39M | Hold |
30,953
| – | – | 0.12% | 37 |
|
|
2021
Q4 | $2.74M | Hold |
30,953
| – | – | 0.22% | 36 |
|
|
2021
Q3 | $2.39M | Hold |
30,953
| – | – | 0.25% | 37 |
|
|
2021
Q2 | $2.58M | Hold |
30,953
| – | – | 0.25% | 46 |
|
|
2021
Q1 | $2.34M | Sell |
30,953
-1,453
| -4% | -$110K | 0.24% | 43 |
|
|
2020
Q4 | $2.84M | Hold |
32,406
| – | – | 0.3% | 31 |
|
|
2020
Q3 | $2.47M | Hold |
32,406
| – | – | 0.27% | 36 |
|
|
2020
Q2 | $4M | Sell |
32,406
-5,803
| -15% | -$716K | 0.49% | 31 |
|
|
2020
Q1 | $3.23M | Sell |
38,209
-1,987
| -5% | -$168K | 0.35% | 33 |
|
|
2019
Q4 | $3.4M | Hold |
40,196
| – | – | 0.29% | 39 |
|
|
2019
Q3 | $2.71M | Sell |
40,196
-4,579
| -10% | -$309K | 0.21% | 40 |
|
|
2019
Q2 | $3.84M | Sell |
44,775
-5,467
| -11% | -$468K | 0.25% | 42 |
|
|
2019
Q1 | $4.46M | Sell |
50,242
-6,936
| -12% | -$616K | 0.27% | 43 |
|
|
2018
Q4 | $4.87M | Sell |
57,178
-8,122
| -12% | -$692K | 0.24% | 42 |
|
|
2018
Q3 | $6.33M | Hold |
65,300
| – | – | 0.21% | 48 |
|
|
2018
Q2 | $6.15M | Buy |
+65,300
| New | +$6.15M | 0.17% | 45 |
|